Kimberly E. Vanover - Chief Scientific Officer @ Engrail Therapeutics

Overview

CB Rank (Person)

Kimberly E. Vanover is the Chief Scientific Officer at Engrail Therapeutics.

Number of Current Jobs

Number of Past Jobs

is the

Chief Scientific Officer

. Additionally,

has had

past job as the

Senior Vice President, Early Stage Clinical Development and Translational Medicine

Organization Name	Title At Company	Start Date	End Date
Intra-Cellular Therapies	Senior Vice President, Early Stage Clinical Development and Translational Medicine	Nov 2018	Mar 2020

Hub Name	CB Rank (Hub)
San Diego Startups Founded in 2019	98,654
West Coast Health Care Companies with Early Stage Venture Funding	55,259
Pharmaceutical Companies with Early Stage Venture Funding	39,526
Western US Health Care Companies with Early Stage Venture Funding	49,032
Life Science Early Stage Companies With Less Than $1B in Revenue	53,761
IMS Health Alumni Founded Companies	96,304
San Diego Health Care Companies	29,766
Pharmaceutical Early Stage Companies With Less Than $50M in Revenue	46,449
Pharmaceutical Early Stage Companies With More Than 10 Employees	37,163
Life Science Early Stage Companies With Less Than $10M in Revenue	99,323

There is no recent news or activity for this profile.